Letter: Predictive Value of Systemic Immune-Inflammatory Index in No-Reflow in Patients with ST-Segment Elevation Myocardial Infarction

Abstract

Get full access to this article

View all access options for this article.

References

Çelik

Karayiğit

Ozkan

Dolu

Kalçık

. Relationship between systemic inflammation index and no-reflow phenomenon in patients with st-segment elevation myocardial infarction. Angiology. 2022;33197221115562. Published online ahead of print 20 July 2022. doi: 10.1177/00033197221115562.

Yang

, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20:6212-6222.

Chen

Liu

, et al. Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: the Dongfeng-Tongji cohort study. Atherosclerosis. 2021;323:20-29.

Candemir

Kiziltunç

Nurkoç

Şahinarslan

. Relationship between Systemic Immune-Inflammation Index (SII) and the Severity of Stable Coronary Artery Disease. Angiology. 2021;72:575-581.

Liu

Chen

, et al. Systemic immune-inflammation index predicts the severity of coronary stenosis in patients with coronary heart disease. Coron Artery Dis. 2021;32:715-720.

Esenboğa

Kurtul

Yamantürk

Tan

Tutar

. Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention. Acta Cardiol. 2022;77:59-65.

Adali

Buber

Kilic

Turkoz

Yilmaz

. Ticagrelor improves systemic immune-inflammation index in acute coronary syndrome patients. Acta Cardiol. 2021;1-7. Published online ahead of print 7 September 2021. doi: 10.1080/00015385.2021.1973770.

Allencherril

Jneid

Atar

, et al. Pathophysiology, diagnosis, and management of the no-reflow phenomenon. Cardiovasc Drugs Ther. 2019;33:589-597.